Sohma Ryoichi, Takahashi Morio, Takada Hiroshi, Takada Hironobu, Kuwayama Hajime
Koshigaya Division of Clinical Research, Institute for Medical Science, Dokkyo University School of Medicine, Koshigaya, Saitama, Japan.
J Gastroenterol Hepatol. 2007 Nov;22(11):1965-70. doi: 10.1111/j.1440-1746.2006.04684.x.
Recently, we reported on the beneficial clinical effects of eicosapentaenoic acid (EPA) in patients with primary biliary cirrhosis (PBC) who were unresponsive to ursodeoxycholic acid (UDCA). In this study we examined the effect of EPA on rat hepatocytes in primary culture.
Hepatocytes were isolated from rat liver by perfusion of collagenase and cultured with or without EPA. Cell damage induced by chenodeoxycholic acid (CDCA) was assessed by WST-8 assay and lactate dehydrogenase (LDH) release. PGE(2) and LTB(4) concentrations in the culture medium were measured by enzyme-linked immunosorbent assay (ELISA). cDNA was made from total RNA that was extracted from hepatocytes, and TaqMan polymerase chain reaction (PCR) was performed to assess the expression of CuZn and Mn superoxide dismutase (SOD) mRNA.
When rat hepatocytes were cultured in the presence of EPA, the damage caused by CDCA was significantly decreased compared with cells cultured without EPA. Cytotoxicity significantly decreased in the presence of EPA. Furthermore, SOD mRNA expression was increased by adding EPA. These findings indicated that EPA protects cells by scavenging superoxide radicals ((*)O(2-)) mediated by SOD production.
EPA has a direct protective effect on rat hepatocytes, which is in agreement with the clinical efficacy of EPA in PBC patients.
最近,我们报道了二十碳五烯酸(EPA)对原发性胆汁性肝硬化(PBC)患者的有益临床效果,这些患者对熊去氧胆酸(UDCA)无反应。在本研究中,我们检测了EPA对原代培养大鼠肝细胞的影响。
通过胶原酶灌注从大鼠肝脏分离肝细胞,并在有或无EPA的情况下进行培养。通过WST-8测定法和乳酸脱氢酶(LDH)释放评估鹅去氧胆酸(CDCA)诱导的细胞损伤。采用酶联免疫吸附测定法(ELISA)测量培养基中PGE(2)和LTB(4)的浓度。从肝细胞提取的总RNA制备cDNA,并进行TaqMan聚合酶链反应(PCR)以评估铜锌和锰超氧化物歧化酶(SOD)mRNA的表达。
当在EPA存在下培养大鼠肝细胞时,与无EPA培养的细胞相比,CDCA引起的损伤显著降低。在EPA存在下细胞毒性显著降低。此外,添加EPA可增加SOD mRNA表达。这些发现表明,EPA通过清除由SOD产生介导的超氧自由基(*O(2-))来保护细胞。
EPA对大鼠肝细胞有直接保护作用,这与EPA对PBC患者的临床疗效一致。